Insider trades
Sheldon Sloan, Chief Officer of Spyre Therapeutics SYRE, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $6.6M. The latest trade was on 06/03.
Sheldon Sloan
Chief Medical Officer
- Company
- Spyre Therapeutics SYRE
- First filing
- 24/10/01
- Trades
- 18 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$6.6M
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/03 | 06/03 | 8,333 sh | $75.00 | $624,975 | −100.0% | |
SYRE | Open-market sale10b5-1 plan | 05/01 | 05/01 | 78,333 sh7 trades | $71.50avg. | $5,600,701.16 | −100.0% |
| Open-market sale10b5-1 plan | 04/01 | 04/03 | 7,958 sh | $50.00 | $397,900 | −100.0% |